Boston Scientific announced that a cybersecurity incident has disrupted its manufacturing and order shipments, likely impacting its third-quarter and full-year 2026 sales and profit forecasts. The company is working with external cybersecurity firms to investigate and restore operations.
The cyberattack on Boston Scientific highlights the vulnerability of critical infrastructure companies to sophisticated cyber threats, potentially disrupting the supply of essential medical devices and impacting patient care.
Boston Scientific disclosed on Tuesday that a significant cybersecurity incident, detected on August 25, 2026, has caused a widespread network outage and severely disrupted its global business operations, including manufacturing and order shipments. The company expects this incident to materially impact its third-quarter and full-year 2026 sales and adjusted profit forecasts.
In response to the attack, Boston Scientific activated incident response protocols and engaged external third-party cybersecurity forensics and containment firms. The company filed a Form 8-K with the U.S. Securities and Exchange Commission on August 26, 2026, to share details of the incident.
Clinical customers were advised to disconnect from the LATITUDE remote patient management network as a precautionary measure to prevent potential cross-contamination between enterprise networks and hospital endpoints. The company's shares fell approximately 4.5% in premarket trading following the disclosure. The exact initial access vector and attribution of the threat actor remain unknown, and a timeline for full restoration has not been stated.